{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T23:28:00Z","timestamp":1770074880857,"version":"3.49.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,11]]},"DOI":"10.7759\/cureus.41681","type":"journal-article","created":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T09:22:07Z","timestamp":1689067327000},"source":"Crossref","is-referenced-by-count":2,"title":["Real-World Effectiveness, Safety, and Tolerability of Cetosomal Minoxidil 5% Alone and a Fixed Drug Combination of Cetosomal Minoxidil 5% With Finasteride 0.1% in the Management of Androgenetic Alopecia (Inbilt Study)"],"prefix":"10.7759","author":[{"given":"Amit","family":"Kerure","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mansukh","family":"Ghalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satyaprakash","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhiraj","family":"Dhoot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanmant","family":"Barkate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.14537","article-title":"Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics","volume":"20","author":"Nestor MS","year":"2021","unstructured":"Nestor MS, Ablon G, Gade A, Han H, Fischer DL. Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics. J Cosmet Dermatol. 2021, 20:3759-81. 10.1111\/jocd.14537","journal-title":"J Cosmet Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-020-00374-y","article-title":"Comparative study to evaluate tolerability of topical 5% minoxidil novel formulation and alcohol-based conventional solutions in treatment of androgenetic alopecia in Indian men: randomized double-blind study","volume":"10","author":"Sarkar R","year":"2020","unstructured":"Sarkar R, Vartak S, Acharya S, Kursam NK, Mane A, Mehta S, Charugulla SN. Comparative study to evaluate tolerability of topical 5% minoxidil novel formulation and alcohol-based conventional solutions in treatment of androgenetic alopecia in Indian men: randomized double-blind study. Dermatol Ther (Heidelb). 2020, 10:469-79. 10.1007\/s13555-020-00374-y","journal-title":"Dermatol Ther (Heidelb)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.02.054","article-title":"The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis","volume":"77","author":"Adil A","year":"2017","unstructured":"Adil A, Godwin M. The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis. J Am Acad Dermatol. 2017, 77:136-141.e5. 10.1016\/j.jaad.2017.02.054","journal-title":"J Am Acad Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3109\/1061186X.2010.483516","article-title":"Transcutol containing vesicles for topical delivery of minoxidil","volume":"19","author":"Mura S","year":"2011","unstructured":"Mura S, Manconi M, Valenti D, Sinico C, Vila AO, Fadda AM. Transcutol containing vesicles for topical delivery of minoxidil. J Drug Target. 2011, 19:189-96. 10.3109\/1061186X.2010.483516","journal-title":"J Drug Target"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4103\/jrptps.JRPTPS_25_21","article-title":"A randomized, double-blind controlled clinical study to evaluate the efficacy and safety of minoxidil topical 2% nanosuspension with aqueous base in the treatment of androgenetic alopecia areata","volume":"10","author":"Mirzaeei S","year":"2021","unstructured":"Mirzaeei S, Barfar A, Mehrandish S, et al.. A randomized, double-blind controlled clinical study to evaluate the efficacy and safety of minoxidil topical 2% nanosuspension with aqueous base in the treatment of androgenetic alopecia areata. J Rep Pharma Sci. 2021, 10:279-86. 10.4103\/jrptps.JRPTPS_25_21","journal-title":"J Rep Pharma Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/cosmetics7020021","article-title":"Topical minoxidil-loaded nanotechnology strategies for alopecia","volume":"7","author":"Santos AC","year":"2020","unstructured":"Santos AC, Pereira-Silva M, Guerra C, et al.. Topical minoxidil-loaded nanotechnology strategies for alopecia. Cosmetics. 2020, 7:21. 10.3390\/cosmetics7020021","journal-title":"Cosmetics"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S214907","article-title":"Minoxidil and its use in hair disorders: a review","volume":"13","author":"Suchonwanit P","year":"2019","unstructured":"Suchonwanit P, Thammarucha S, Leerunyakul K. Minoxidil and its use in hair disorders: a review. Drug Des Devel Ther. 2019, 13:2777-86. 10.2147\/DDDT.S214907","journal-title":"Drug Des Devel Ther"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.15570\/actaapa.2016.12","article-title":"Efficacy and safety of 5% minoxidil topical foam in male pattern hair loss treatment and patient satisfaction","volume":"25","author":"Hasanzadeh H","year":"2016","unstructured":"Hasanzadeh H, Nasrollahi SA, Halavati N, Saberi M, Firooz A. Efficacy and safety of 5% minoxidil topical foam in male pattern hair loss treatment and patient satisfaction. Acta Dermatovenerol Alp Pannonica Adriat. 2016, 25:41-4. 10.15570\/actaapa.2016.12","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"key":"ref9","unstructured":"PubChem. Patent summary for US-2014234428-A1 (2013). (2023). Accessed: 15 January, 2023: https:\/\/pubchem.ncbi.nlm.nih.gov\/patent\/US-2014234428-A1."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2003.10.290","article-title":"Rapid onset of action of minoxidil 5% topical solution in a 4-month German observational study on both patients and physicians","volume":"50","author":"Rundegren J","year":"2004","unstructured":"Rundegren J. Rapid onset of action of minoxidil 5% topical solution in a 4-month German observational study on both patients and physicians. J Am Acad Dermatol. 2004, 50:91. 10.1016\/j.jaad.2003.10.290","journal-title":"J Am Acad Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.124088","article-title":"A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men","volume":"47","author":"Olsen EA","year":"2002","unstructured":"Olsen EA, Dunlap FE, Funicella T, Koperski JA, Swinehart JM, Tschen EH, Trancik RJ. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol. 2002, 47:377-85. 10.1067\/mjd.2002.124088","journal-title":"J Am Acad Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2007.04.012","article-title":"A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men","volume":"57","author":"Olsen EA","year":"2007","unstructured":"Olsen EA, Whiting D, Bergfeld W, et al.. A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol. 2007, 57:767-74. 10.1016\/j.jaad.2007.04.012","journal-title":"J Am Acad Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2003.05435.x","article-title":"The effects of minoxidil, 1% pyrithione zinc and a combination of both on hair density: a randomized controlled trial","volume":"149","author":"Berger RS","year":"2003","unstructured":"Berger RS, Fu JL, Smiles KA, Turner CB, Schnell BM, Werchowski KM, Lammers KM. The effects of minoxidil, 1% pyrithione zinc and a combination of both on hair density: a randomized controlled trial. Br J Dermatol. 2003, 149:354-62. 10.1046\/j.1365-2133.2003.05435.x","journal-title":"Br J Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2003.06.014","article-title":"A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss","volume":"50","author":"Lucky AW","year":"2004","unstructured":"Lucky AW, Piacquadio DJ, Ditre CM, et al.. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss. J Am Acad Dermatol. 2004, 50:541-53. 10.1016\/j.jaad.2003.06.014","journal-title":"J Am Acad Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2007.0187","article-title":"A randomized, placebo-controlled trial of 1% topical minoxidil solution in the treatment of androgenetic alopecia in Japanese women","volume":"17","author":"Tsuboi R","year":"2007","unstructured":"Tsuboi R, Tanaka T, Nishikawa T, et al.. A randomized, placebo-controlled trial of 1% topical minoxidil solution in the treatment of androgenetic alopecia in Japanese women. Eur J Dermatol. 2007, 17:37-44. 10.1684\/ejd.2007.0187","journal-title":"Eur J Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.09.724","article-title":"A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women","volume":"65","author":"Blume-Peytavi U","year":"2011","unstructured":"Blume-Peytavi U, Hillmann K, Dietz E, Canfield D, Garcia Bartels N. A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women. J Am Acad Dermatol. 2011, 65:1126-1134.e2. 10.1016\/j.jaad.2010.09.724","journal-title":"J Am Acad Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/164311-real-world-effectiveness-safety-and-tolerability-of-cetosomal-minoxidil-5-alone-and-a-fixed-drug-combination-of-cetosomal-minoxidil-5-with-finasteride-01-in-the-management-of-androgenetic-alopecia-inbilt-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:04:27Z","timestamp":1707509067000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/164311-real-world-effectiveness-safety-and-tolerability-of-cetosomal-minoxidil-5-alone-and-a-fixed-drug-combination-of-cetosomal-minoxidil-5-with-finasteride-01-in-the-management-of-androgenetic-alopecia-inbilt-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,11]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.41681","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,11]]}}}